These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 6965803)

  • 1. Role of the spleen in the growth of a murine B cell leukemia.
    Kotzin BL; Strober S
    Science; 1980 Apr; 208(4439):59-61. PubMed ID: 6965803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BCL1, a murine model of prolymphocytic leukemia. II. Morphology and ultrastructure.
    Muirhead MJ; Holbert JM; Uhr JW; Vitetta ES
    Am J Pathol; 1981 Dec; 105(3):306-15. PubMed ID: 6976124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of the spleen in tumor growth kinetics of the murine B cell leukemia (BCL1).
    Slavin S; Morecki S; Weiss L
    J Immunol; 1980 Feb; 124(2):586-9. PubMed ID: 6965384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BCL1, a murine model of prolymphocytic leukemia. I. Effect of splenectomy on growth kinetics and organ distribution.
    Muirhead MJ; Isakson PC; Krolick KA; Uhr JW; Vitetta ES
    Am J Pathol; 1981 Dec; 105(3):295-305. PubMed ID: 7032308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of the spleen in preleukemic development of a murine retrovirus-induced promonocytic leukemia.
    Nason-Burchenal K; Wolff L
    Cancer Res; 1992 Oct; 52(19):5317-22. PubMed ID: 1394137
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Growth inhibition of a B cell leukemia: evidence implicating an anti-idiotype immune response for protective tumor immunity.
    Ciavarra RP; Vitetta ES; Forman J
    J Immunol; 1986 Aug; 137(4):1371-5. PubMed ID: 2426362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunosuppression in mice after inoculation with 334C, a murine lymphatic leukemia-inducing virus.
    Schenk PJ; Buffett RF
    J Natl Cancer Inst; 1977 Mar; 58(3):665-71. PubMed ID: 190412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ultrastructural, cell membrane, and cytogenetic characteristics of B-cell leukemia, a murine model of chronic lymphocytic leukemia.
    Slavin S; Weiss L; Morecki S; Bassat HB; Leizerowitz R; Gamliel H; Korkesh A; Voss R; Polliack A
    Cancer Res; 1981 Oct; 41(10):4162-6. PubMed ID: 6974594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor dormancy. I. Regression of BCL1 tumor and induction of a dormant tumor state in mice chimeric at the major histocompatibility complex.
    Siu H; Vitetta ES; May RD; Uhr JW
    J Immunol; 1986 Aug; 137(4):1376-82. PubMed ID: 3525678
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of phenylhydrazine pretreatment on splenectomized Rauscher leukemia virus-infected mice.
    Bergson A; Lobue J; Gordon AS; Fredickson TN
    J Surg Oncol; 1978; 10(3):239-43. PubMed ID: 651372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Demonstration and characterization of virus released by murine B cell leukemia cells (BCL1).
    Morecki S; Slavin S; Weiss L; Weigensberg M; Friedman A; Kotler M
    Leuk Res; 1984; 8(5):821-32. PubMed ID: 6333565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of splenectomy on the development of leukemia in male mice of the ICRC strain.
    Pai SR; Ranadive KJ
    Life Sci II; 1971 Apr; 10(8):475-9. PubMed ID: 5089344
    [No Abstract]   [Full Text] [Related]  

  • 13. Immunofluorescence and histologic studies of virus-induced murine lymphocytic leukemias.
    Dawson PJ; Dresler SL; Fieldsteel AH
    J Natl Cancer Inst; 1976 May; 56(5):1047-50. PubMed ID: 186613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Haemopoietic progenitor-cell responses in mice with the transplanted lymphoid leukaemia ABE-8.
    McCarthy JH
    Br J Cancer; 1979 Jul; 40(1):144-51. PubMed ID: 313215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of IgH V-region genes on the growth kinetics of a murine B cell leukemia (BCL1).
    Ciavarra R; Forman J
    J Immunol; 1981 Jan; 126(1):54-8. PubMed ID: 6778917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo therapy of a murine B cell tumor (BCL1) using antibody-ricin A chain immunotoxins.
    Krolick KA; Uhr JW; Slavin S; Vitetta ES
    J Exp Med; 1982 Jun; 155(6):1797-809. PubMed ID: 6804591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T-cell regulation of erythropoiesis during acute lymphoblastic leukemia.
    Bacon ER; Sing AP; Troutner JC; Reinisch CL
    Exp Hematol; 1985 Feb; 13(2):104-10. PubMed ID: 3871705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proliferative response of murine B-cell leukemia (BCL1) to poly(L-lysine).
    Morecki S; Flechner Y; Slavin S
    Cell Immunol; 1985 Feb; 90(2):392-400. PubMed ID: 3871370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Allogeneic cell therapy in murine B-cell leukemia (BCL1): 1. Alloimmune-mediated graft-versus-leukemia (GVL) effects induced by unmodified and in vitro rIL-2-activated bone marrow and lymphocytes from different lymphoid compartments.
    Weiss L; Reich S; Slavin S
    Cytokines Cell Mol Ther; 1999 Sep; 5(3):145-52. PubMed ID: 10641572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression and elimination of BCL1 leukemia by allogeneic bone marrow transplantation.
    Weiss L; Morecki S; Vitetta ES; Slavin S
    J Immunol; 1983 May; 130(5):2452-5. PubMed ID: 6339628
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.